FindTrial
Sign In

The influence of recompensation for hepatocellular carcinoma in patients with HBV-related decompensated cirrhosis

The influence of recompensation for hepatocellular carcinoma in patients with HBV-related decompensated cirrhosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091564
Enrollment
Unknown
Registered
2024-10-30
Start date
2024-11-05
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Interventions

decompensation group:N/A
recompensation group:N/A
compensation group:N/A

Sponsors

The First Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Over 18 years old; 2. Up to 3 tumor nodules with q = 5cm per nodule 3. Hepatitis B patients with cirrhosis 4. No signs of vascular or biliary invasion; 5. No extrahepatic metastasis

Exclusion criteria

Exclusion criteria: 1. Other serious diseases (poor cardiopulmonary function/kidney failure). 2. Cirrhosis with other causes.

Design outcomes

Primary

MeasureTime frame
Overall survival;Progression free survival;—

Countries

China

Contacts

Public ContactHang Zheng

The First Affiliated Hospital of Wenzhou Medical University

3130102039@zju.edu.cn+86 138 6860 9781

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026